search
Back to results

DuraMesh Laparotomy Study

Primary Purpose

Laparotomy, Suture; Complications, Mechanical, Hernia Incisional

Status
Withdrawn
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Duramesh suturable mesh for laparotomy closure
Conventional suture for laparotomy closure
Sponsored by
Mesh Suture Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Laparotomy

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Midline laparotomy greater than 5 cm in length
  • Urgent or emergent surgery following trauma
  • Urgent or emergent surgery for diverticulitis
  • Large or small bowel obstruction, acute abdomen, or intra-abdominal hemorrhage.
  • Open abdomen after midline laparotomy.

Exclusion Criteria:

  • Prior hernia repair or existing abdominal mesh
  • Metastatic cancer
  • Pregnancy
  • Immunosuppression.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm 3

    Arm Type

    Experimental

    Experimental

    Experimental

    Arm Label

    Duramesh suturable mesh for laparotomy closure

    Conventional suture closure for laparotomy closure

    Open abdomen group closed in delayed fashion with Duramesh

    Arm Description

    Patients undergoing a midline laparotomy for trauma or emergency surgery will be closed with Duramesh suturable mesh.

    Patients randomized to conventional laparotomy closure will be closed using size 1 slowly-absorbing polydiaxonone (PDS) single strand or looped suture, based on surgeon preference.

    Patients undergoing delayed primary closure of an open abdomen will also be studied. 20 study patients undergoing delayed primary closure of an open abdomen will be closed with Number 1 or Number 2 Duramesh

    Outcomes

    Primary Outcome Measures

    Surgical site infection
    Superficial or deep infection of the surgical site
    Surgical site infection
    Superficial or deep infection of the surgical site
    Surgical site infection
    Superficial or deep infection of the surgical site
    Surgical site infection
    Superficial or deep infection of the surgical site

    Secondary Outcome Measures

    Surgical site occurrence
    Any complication related to the surgical site, including hematoma, seroma, dehiscence, fistula, small bowel obstruction, exposed suture, return to the operating room, readmission, or mortality
    Surgical site occurrence
    Any complication related to the surgical site, including hematoma, seroma, dehiscence, fistula, small bowel obstruction, exposed suture, return to the operating room, readmission, or mortality
    Surgical site occurrence
    Any complication related to the surgical site, including hematoma, seroma, dehiscence, fistula, small bowel obstruction, exposed suture, return to the operating room, readmission, or mortality
    Surgical site occurrence
    Any complication related to the surgical site, including hematoma, seroma, dehiscence, fistula, small bowel obstruction, exposed suture, return to the operating room, readmission, or mortality
    Intraoperative and hospitalization endpoints
    Details regarding abdominal wall closure
    Intraoperative and hospitalization endpoints
    Length of hospital stay
    Intraoperative and hospitalization endpoints
    Length of the laparotomy incision and length of suture remnant
    Intraoperative and hospitalization endpoints
    Size of Duramesh used
    Hernia formation
    Clinical development of an incisional hernia
    Patient reported outcomes
    NRS pain scale
    Patient reported outcomes
    NRS pain scale
    Patient reported outcomes
    HerQles
    Patient reported outcomes
    SF-36
    Patient reported outcomes
    HerQles
    Patient reported outcomes
    SF-36
    Patient reported outcomes
    NRS pain scale

    Full Information

    First Posted
    May 23, 2019
    Last Updated
    September 7, 2022
    Sponsor
    Mesh Suture Inc.
    Collaborators
    Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, University of Maryland
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03966768
    Brief Title
    DuraMesh Laparotomy Study
    Official Title
    DuraMesh Laparotomy Closure Following Trauma and Emergency Surgery
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    September 2022
    Overall Recruitment Status
    Withdrawn
    Why Stopped
    Mutual decision Walter Reed/U Maryland and Mesh Suture Inc.
    Study Start Date
    October 15, 2023 (Anticipated)
    Primary Completion Date
    December 31, 2024 (Anticipated)
    Study Completion Date
    December 31, 2025 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Mesh Suture Inc.
    Collaborators
    Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, University of Maryland

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    Yes
    Device Product Not Approved or Cleared by U.S. FDA
    Yes
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    This is a multisite randomized control proof-of-concept trial to evaluate the safety of Duramesh laparotomy closure in the trauma and emergency laparotomy setting. The study will be performed at University of Maryland Shock Trauma Center and Walter Reed National Military Medical Center. One hundred (100) patients will be randomized (2:1) to Duramesh laparotomy closure versus conventional suture closure. After the patient has been confirmed to be a candidate for the trial, randomization will be performed in the operating room upon completion of the index abdominal procedure. Duramesh will be provided for patients assigned to the Duramesh treatment arm. Patients will be followed for 1 year following laparotomy closure at follow-up intervals of 1 month, 3 months, 6 months, and 12 months.
    Detailed Description
    Primary Laparotomy Closure Treatment 1) Study Group - Duramesh Laparotomy Closure (DLC) Treatment 2) Control Group - Conventional Suture Closure (CSC) Patients undergoing a midline laparotomy for trauma or emergency surgery will have their abdominal wall laparotomy incision closed with size 0 Duramesh suturable mesh. Patients randomized to conventional laparotomy closure will be closed using size 1 slowly-absorbing (PDS) single strand or looped suture, based on surgeon preference. While it would be preferable to identify a single conventional suture to serve as the control group, polling of potential participating surgeons demonstrated a preference for both single strand and looped sutures to be available for use in the conventional suture closure group. Both Duramesh and conventional sutures will be placed using a standardized closure technique that incorporates 1cm wide bites and 1cm spacing, as this is the established technique for trauma and emergency laparotomy closure at both participating institutions. An effort to quantify suture to wound length ratio will be made in an effort to confirm standardization of closure technique between groups. The small-bites surgical closure technique popular in Europe has not been adopted by trauma and emergency surgeons at either institution given concerns related to early dehiscence and the inability to extrapolate the STITCH trial data to a US trauma population. The surgeons at both institutions do not believe it acceptable to generalize the European trial with a mean BMI of 24 to the United States population, nor do they believe it wise to close the abdominal wall with a 2-0 polydioxanone suture, as this technique trended towards a higher rate of acute fascial dehiscence (burst abdomen). All patients will be assessed for post-operative complications ( i . e . , infection, seroma, hematoma), a t 1 , 3 , 6 , and 12 months p o s t o p e r a t i v e l y . Patient will also be assessed for incisional hernia formation at the same post-operative time points (1, 3, 6, 12 months). Hernia outcomes will be based on physical examination, with ultrasound used for any uncertainties. While surveillance imaging has been shown to be more sensitive for hernia detection, the primary purpose of this study is to compare the safety profile of Duramesh laparotomy closure to standard closure technique. Surveillance imaging for hernia identification is not a part of standard clinical practice at the participating study sites. The rate of clinically relevant hernias found on physical exam will be used to inform future efficacy studies, where routine surveillance imaging will be incorporated into the study design. In addition to the patients undergoing primary laparotomy closure following an open trauma or emergency abdominal surgery, an additional subset of 20 patients undergoing delayed primary closure of an open abdomen will also be studied. These patients represent a particularly challenging clinical problem, for which there is no standard approach to repair. All 20 study patients undergoing delayed primary closure of an open abdomen will be closed with #1 or #2 Duramesh and followed according to the same post-operative protocol as those undergoing primary laparotomy closure. This subgroup is too small for randomization to provide useful data for comparison, and thus will be used to provide only a descriptive analysis of this early experience with delayed Duramesh closure of the open abdomen. The safety of Duramesh closure in this patient population can be extrapolated from the previously referenced experience of mesh strip closures in contaminated incisional hernias.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Laparotomy, Suture; Complications, Mechanical, Hernia Incisional

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    Randomized Clinical Trial
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    0 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Duramesh suturable mesh for laparotomy closure
    Arm Type
    Experimental
    Arm Description
    Patients undergoing a midline laparotomy for trauma or emergency surgery will be closed with Duramesh suturable mesh.
    Arm Title
    Conventional suture closure for laparotomy closure
    Arm Type
    Experimental
    Arm Description
    Patients randomized to conventional laparotomy closure will be closed using size 1 slowly-absorbing polydiaxonone (PDS) single strand or looped suture, based on surgeon preference.
    Arm Title
    Open abdomen group closed in delayed fashion with Duramesh
    Arm Type
    Experimental
    Arm Description
    Patients undergoing delayed primary closure of an open abdomen will also be studied. 20 study patients undergoing delayed primary closure of an open abdomen will be closed with Number 1 or Number 2 Duramesh
    Intervention Type
    Device
    Intervention Name(s)
    Duramesh suturable mesh for laparotomy closure
    Intervention Description
    Patients undergoing laparotomy will be closed with Duramesh suturable mesh
    Intervention Type
    Device
    Intervention Name(s)
    Conventional suture for laparotomy closure
    Intervention Description
    Patients undergoing laparotomy will be closed with conventional polydiaxonone suture
    Primary Outcome Measure Information:
    Title
    Surgical site infection
    Description
    Superficial or deep infection of the surgical site
    Time Frame
    1 month
    Title
    Surgical site infection
    Description
    Superficial or deep infection of the surgical site
    Time Frame
    3 months
    Title
    Surgical site infection
    Description
    Superficial or deep infection of the surgical site
    Time Frame
    6 months
    Title
    Surgical site infection
    Description
    Superficial or deep infection of the surgical site
    Time Frame
    12 months
    Secondary Outcome Measure Information:
    Title
    Surgical site occurrence
    Description
    Any complication related to the surgical site, including hematoma, seroma, dehiscence, fistula, small bowel obstruction, exposed suture, return to the operating room, readmission, or mortality
    Time Frame
    1 month
    Title
    Surgical site occurrence
    Description
    Any complication related to the surgical site, including hematoma, seroma, dehiscence, fistula, small bowel obstruction, exposed suture, return to the operating room, readmission, or mortality
    Time Frame
    3 months
    Title
    Surgical site occurrence
    Description
    Any complication related to the surgical site, including hematoma, seroma, dehiscence, fistula, small bowel obstruction, exposed suture, return to the operating room, readmission, or mortality
    Time Frame
    6 months
    Title
    Surgical site occurrence
    Description
    Any complication related to the surgical site, including hematoma, seroma, dehiscence, fistula, small bowel obstruction, exposed suture, return to the operating room, readmission, or mortality
    Time Frame
    12 months
    Title
    Intraoperative and hospitalization endpoints
    Description
    Details regarding abdominal wall closure
    Time Frame
    Within 30 days
    Title
    Intraoperative and hospitalization endpoints
    Description
    Length of hospital stay
    Time Frame
    Within 30 days
    Title
    Intraoperative and hospitalization endpoints
    Description
    Length of the laparotomy incision and length of suture remnant
    Time Frame
    Within 30 days
    Title
    Intraoperative and hospitalization endpoints
    Description
    Size of Duramesh used
    Time Frame
    Within 30 days
    Title
    Hernia formation
    Description
    Clinical development of an incisional hernia
    Time Frame
    anytime within 12 months
    Title
    Patient reported outcomes
    Description
    NRS pain scale
    Time Frame
    3 months
    Title
    Patient reported outcomes
    Description
    NRS pain scale
    Time Frame
    6 months
    Title
    Patient reported outcomes
    Description
    HerQles
    Time Frame
    6 months
    Title
    Patient reported outcomes
    Description
    SF-36
    Time Frame
    6 months
    Title
    Patient reported outcomes
    Description
    HerQles
    Time Frame
    12 months
    Title
    Patient reported outcomes
    Description
    SF-36
    Time Frame
    12 months
    Title
    Patient reported outcomes
    Description
    NRS pain scale
    Time Frame
    12 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    75 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Midline laparotomy greater than 5 cm in length Urgent or emergent surgery following trauma Urgent or emergent surgery for diverticulitis Large or small bowel obstruction, acute abdomen, or intra-abdominal hemorrhage. Open abdomen after midline laparotomy. Exclusion Criteria: Prior hernia repair or existing abdominal mesh Metastatic cancer Pregnancy Immunosuppression.
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Jason M Souza, MD
    Organizational Affiliation
    Walter Reed Army Institute of Research (WRAIR)
    Official's Role
    Principal Investigator
    First Name & Middle Initial & Last Name & Degree
    Thomas Scalea, MD
    Organizational Affiliation
    U Maryland Shock Trauma
    Official's Role
    Study Director

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    IPD Sharing Plan Description
    As per the sponsor wishes
    Citations:
    PubMed Identifier
    29108644
    Citation
    Dumanian GA, Lanier ST, Souza JM, Young MW, Mlodinow AS, Boller AM, Mueller KH, Halverson AL, McGee MF, Stulberg JJ. Mesh sutured repairs of contaminated incisional hernias. Am J Surg. 2018 Aug;216(2):267-273. doi: 10.1016/j.amjsurg.2017.10.025. Epub 2017 Oct 25.
    Results Reference
    background
    PubMed Identifier
    27757361
    Citation
    Lanier ST, Dumanian GA, Jordan SW, Miller KR, Ali NA, Stock SR. Mesh Sutured Repairs of Abdominal Wall Defects. Plast Reconstr Surg Glob Open. 2016 Sep 28;4(9):e1060. doi: 10.1097/GOX.0000000000001060. eCollection 2016 Sep.
    Results Reference
    background
    PubMed Identifier
    26154703
    Citation
    Dumanian GA, Tulaimat A, Dumanian ZP. Experimental study of the characteristics of a novel mesh suture. Br J Surg. 2015 Sep;102(10):1285-92. doi: 10.1002/bjs.9853. Epub 2015 Jul 8.
    Results Reference
    background
    PubMed Identifier
    25626817
    Citation
    Souza JM, Dumanian ZP, Gurjala AN, Dumanian GA. In vivo evaluation of a novel mesh suture design for abdominal wall closure. Plast Reconstr Surg. 2015 Feb;135(2):322e-330e. doi: 10.1097/PRS.0000000000000910.
    Results Reference
    background

    Learn more about this trial

    DuraMesh Laparotomy Study

    We'll reach out to this number within 24 hrs